Functional interactions among members of the myc superfamily and potential relevance to cutaneous growth and development

Journal of Investigative Dermatology Symposium Proceedings

Volumn 1, Issue 2, 1996, Pages 128-135

  Chin, Lynda ^a   Liégeois, Nanette ^a   Depinho, Ronald A ^a   Schreiber Agus, Nicole ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Oncogene; Repressor; Transcription

Indexed keywords

MYC PROTEIN; REPRESSOR PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; SIN3 PROTEIN, S CEREVISIAE; TRANSCRIPTION FACTOR;

ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; GENE THERAPY; GROWTH, DEVELOPMENT AND AGING; HUMAN; NEOPLASM; PHYSIOLOGY; REVIEW; SKIN; SKIN DISEASE;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; GENE THERAPY; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SKIN; SKIN DISEASES; TRANSCRIPTION FACTORS;

EID: 0030112302     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (117)

1. Adams J, Harris A, Pinkert C, Corcoran L, Alexander W, Cory S, Palmiter R, Brinster R: The c-myc oncogene driven by immunoglobuliii enhancers induces lymphoid malignancy in transgemc mice. Nature 318:533-538, 1985
2. Albert RE, Phillips ME, Bennett P, Burns FJ, Heimbach R: The morphology and growth characteristics of radiation-induced epithelial skin tumors in the rat. CattffrRes 29:658-668, 1969
3. Alex R, Sozeri O, Dildrop R: Determination of the DNA sequence recognized by the bHLH-zip domain of the N-Myc protein. Nucleic Acids Res 20:2257-2263, 1992
4. Amati B, Littlewood TD, Evan GI, Land H: The c-Myc protein induces cell cycle progression and apoptosis tlirough dimerization with Max. EMBO J 12:5083-5087, 1993a
5. Amati B, Brooks MW, Levy M, Littlewood TD, Evan GI, Land H: Oncogenic activity of the c-Myc protein requires dimerization with Max. Celt 72:233-245, 1993b
6. Ayer DE, Eisenman RN: A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 7:2110-2119, 1993
7. Ayer DE, Kretzner L, Eisenman RN: Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222, 1993
8. Ayer DE, Lawrence QA, Eisenman RN: The ammo-terminus of Mad mediates ternary complex formation with mammalian homologs of the yeast represser Sin3 and is required for Mad:Max transcriptional repression. Cell 80:767-776, 1995
9. Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV: Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol Cell Biol 12:3130-3137, 1992
10. Beijersbergen RL, Hijmans EM, Zhu L, Bernards R: Interaction of c-Myc with the pRb-related protein p!07 results in inhibition of c-Myc-mediated transactivation. EMBO J 13:4080-4086, 1994
11. Bello-Fernandez C, Packham G, Cleveland JL: The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sa USA 90:7804-7808, 1993
12. Benvenisty N, Leder A, Kuo A, Leder P: An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev 6:2513-2523, 1992
13. Berberich SJ, Cole MD: Casein kinase II inhibits the DNA-binding activity of Max homodimers but no, Myc/Max heterodimers. Genes Dev 6:166-176, 1992
14. Birrer MJ, Segal S, DeGiü ve JS. Kaye F, Sausville EA, Minna JD: L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol Cell Biol 8:2668-2673, 1988
15. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H: Sequencespecific DNA binding by the c-myc protein. Science 250:1149-1151, 1990
16. Blackwood EM, Eisenman RN: Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc. Science 251:1211-1217, 1991
17. Blackwood EM, Luscher B, Eisenman RN: Myc and Max associate in vivo. Genes Dev 6:71-80, 1992
18. Bums FJ, Albert RE: Dose-response for rat skin tumors induced by single and split doses of argon ions. In: Biological and Medical Research trith Accelerated Heavy Ions at the Bevalac. University of California Press, Berkeley, 1981, pp 233-236
19. Charron J, Malynn BA, Fisher P, See wart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW: Embryonic lethality in mice homozygous for a targeted disruption of die N-myc gene. Genes Dev 6:2248-2257, 1992
20. Chen J, Willingham T, Margraf LR, Schreiber-Agus N, DePinho RA, Nisen PD: Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and die malignant phenotype of human brain tumour cells. Nature Med 1:638-643, 1995
21. Chin L, Schrciber-Agus N, PeUicer I, Chen K, Lee H-W, Dudast M, Cordon-Cardo C, DePinho RA: Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc Nad Acad Sci USA 92:8488-8492, 1995
22. Coppola JA, Cole MD: Constitutive c-myc oncogene expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature (London) 320: 760-763, 1986
23. Cowell IG: Repression versus activation in the control of gene transcription. Trends Biochem Sci 19:38-42, 1994
24. Dang CV, Lee WMF: Identification of the human c-Myc protein nuclear translocation signal. Mol Cell Biol 8:4048-4054. 1988
25. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A: A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 7:671-682, 1993
26. Daya-Grosjean L, Robert C, Drougard C, Suarez H, Sarasin A: High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient Xeroderma Pigmentosum patients. Cancer Res 53:1625-1629, 1993
27. DePinho RA, Hatten KS, Tesfaye A, Yancopoulos GD, Alt FW: The human myc gene family: structure and activity of L-myc and an L-myc pseudogene. Genes Dev 1:1311-1326, 1987
28. DePinho RA, Schreiber-Agus N, Alt FW: myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57:1-46, 1991
29. Dildrop R, Ma A, Zimmerman K, Hsu E, Tesfaye A. DePinho RA, Alt FW: IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBOJ 8:1121-1128, 1989
30. Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S: Expression of a transfected human c-myc oncogene inliibits differentiation of a mouse erythroleukacmia cell line. Nature (London) 322:7-18-750, 1986
31. Dotto GP, Gilman MZ, Maruyama M, Weinberg RA: c-myc and c-fos expression in differentiating mouse primary keratinocytes. EMBOJ 5:2853-2857, 1986
32. Downs KM, Martin GR, Bishop JM: Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev 3:860-869,1989
33. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV: Mutation of the MXI1 gene in prostate cancer. Nature Ceil 9:249-255, 1995
34. Edelhoff S, Ayer DE, Zcrvos AS, Steingrimsson E, Jenkins NA, Copeland NG, Eisenman RN, Brent R, Disteche CM: Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 9:665-668, 1994
35. Endo T, Nadal-Ginard B: Transcriptional and posttramcriptional control of c-myc during myogcncsis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. Mol Cell Biol 6:1412-1421, 1986
36. Freytag SO, Dang CV, Lee WM: Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Groulh & Dif 1:339-343, 1990
37. Gartc SJ, Bums FJ, Ashkcnazi-Kimmel T, Cosma GN, Sawey MJ: An experimental model for oncogene activation during tumor progression in vivo. Anticancer Res 9:1439-1446, 1989
38. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-rcsponsive promoters. Proc Natl Acad Sci USA 89:5547-5551, 1992
39. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769, 1995
40. Grady EF, Schwab M, Roscnau W: Expression of N-myc and c-src during the development of fetal human brain. Camer Res 47:2931-2936, 1987
41. Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-Favera R: Binding and suppression of the Myc transcriptional activation domain by p!07. Science 264:251-254, 1994
42. Gupta S, Seth A, Davis RJ: Transacrivation of gene expression by Myc is inhibited by mutation at the phosphorylati'on sites Thr-58 and Ser-62. Proc Natl Acad Sci USA 90:3216-3220, 1993
43. Halazonetis TD, Kandil AN: Determination of the c-Myc DNA-binding site. Proc Natl AcaJ Sci USA 88:6162-6166, 1991
44. Heikkila R, Schwab G, Wickstrom E, Loke SL, Pluznik DH, Watt R, Neckers LM: A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from GO to Gl. Nature (London) 328:445-449, 1987
45. Herskowitz I: Functional inactivation of genes by dominant negative mutations. Nature (London) 329:219-222, 1987
46. Howard TA, Rochelle JM, Saunders AM, Seldin MF: A linkage map of mouse chromosome 8: further definition of homologous linkage relationships between mouse chromosome 8 and human chromosomes 8, 16, and 19. Cenamics 10:207-213, 1991
47. Jackson T, Allard MF, Srecnan CM, Doss LK, Bishop SP, Swain JL: The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 10:3709-3716, 1990
48. Kato GJ, Barret J, Villa-Garcia M, Dang CV: An amino-terminal c-Myc domain required for neoplasric transformation activates transcription. AM Cell Biol 10:5914-5920, 1990
49. Kato GJ, Lee WMF, Chen L, Dang CV: Max: functional domains and interaction with c-Myc. Cents Dcv 6:81-92, 1992
50. Kerkhoff E, Bister K, Klempnauer K-H: Sequence-specific DNA binding by Myc proteins. Proc Natl AcaJ Sci USA 88:4323-4327, 1991
51. Kilkenny AE, Morgan D, Spangler EF, Yuspa SH: Correlation of initiating potency of skin carcinogens with potency to induce resistance to terminal differentiation in cultured mouse kerarinocytcs. Cancer Res 45:2219-2225, 1985
52. Kohl NE, Katoshi N, Schreck RR, Bruns G, Latt SA, Gilbert F, Alt FW: Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35:359-367, 1983
53. Koskinen PJ, Ayer DE, Eisenman RN: Repression of Myc-Ras Cotransformation by Mad Is Mediated by Multiple Protein-Protein Interactions. Cell Groii'th & Differentiation 6:623-629, 1995
54. Kretzner L, Blackwood EM, Eisenman RN: Myc and Max proteins possess distinct transcriptional activities. Nature (London) 359:426-429, 1992
55. Lachman HM, Skoultchi AI: Expression of c-myc changes during differentiation of mouse erythrolcukemia cells. Nature (London) 310:592-602, 1984
56. Lahoz EG, Xu L, Schreiber-Agus N, DePinho RA: Suppression of Myc, but not Ela, transformation activity by Max-associated proteins. Mad and Mxil. Prof Natl AcaJ Sci USA 91:5503-5507, 1994
57. Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304:596-602, 1983
58. Larsson L-G, Pettersson M, Oberg F, Nilsson K, Luscher B: Expression of mad, mxil, max and c-myc during induced differentiation of hematopoictic cells: opposite regulation of mad and c-myr. Oncogene 9:1247-1252, 1993
59. Lcgouy E, DePinho RD, Zimmerman K, Collum R, Yancopoulos G, Mitsock L, Kriz R, Alt FW: Structure and expression of the murine L-inyc gene. EMBO J 6:3359-3366, 1987
60. Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB: c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBOJ 13:4070-4079, 1994
61. Ma A, Moroy T, Collum R, Winrraub H. Alt FW, Blackwell TK: DNA binding by N-and L-Myc protein. Oncocene 8:1093-1098, 1993
62. Makela TP, Koskinen PJ, Vastrik I, Alitalo K: Alternative forms of Max as enhancers or suppressors of Myc-Ras cotramformation. Scieixe 256:373-376, 1992
63. Marcu KB, Bossone SA, Patel AJ: myc function and regulation. Ann Rev Biochem 61:809-860, 1992
64. Morgenbesser SD, Schreiber-Agus N, Bidder M, Mahon KA, Overbeek PA, Hornet J, DePinho RA: Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation m vivo. EMBOJ 14:734-756, 1995
65. Moroy T, Fisher P, Guidos C, Ma A, Zimmerman K, Tesfaye A, DePinho RA, Weissman I, Alt FW: IgH-enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis. EMBOJ 9:3659-3666, 1990
66. Moroy T, Alt FW, DePinho RA: Use of transgenic mice to study normal and abnormal mammalian development, tn: Broder S (ed.). Molecular Foundation of Oncology. Wiley, New York, 1991, pp 455-487
67. Mugrauer G, Alt FW, Ekblom P: N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by m situ hybridization. J Cell Biol 107:1325-1335, 1988
68. Mukherjee B, Morgenbesser SD, DePinho RA: Myc-family oncoproteins function through a common pathway to transform normal cells in culture: cross interfer-ence by Max and trans-acting dominant mutants. Genes Dev 6:1480-1492, 1992
69. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115, 1988
70. Munger K, Pietenpol JA, Pittelkow MR, Holt JT, Moses HL: Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Grou-th & Dig3:291-298, 1992
71. Nasmytll K, Stillman D, Kipling D: Both positive and negative regulators of HO transcription are required for mother-cell-specific mating-type switching in yeast. Cell 48:579-587, 1987
72. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsh IR, McBride OW, Bertness V, Hollis GF, Minna JD: L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature (London) 318:69-73, 1985
73. Pelisson I, Solcr C, Pechoux C, Chignol MC, Viac J, Euvrard S, Chardonnet Y: c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions. J Denn Science 3:56-67, 1992
74. Pfeiffer-Ohlsson S, Rydnert J, Goustin AS, Larsson E, Betsholz C, Ohlsson R: Cell-type-specific pattern of myc proto-oncogene expression in developing human embryos. Proc Natl Acad Sci USA 82:5050-5054, 1985
75. Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M: Repression of cyclin Dl: a novel function of MYC. Mol Cell Biol 14:4032-4043, 1994
76. Pietenpol JA, Holt JT, Stein RW, Moses HL: Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Nail Acad Sci USA 87:3758-3762, 1990
77. Prendergast GC, Ziff EB: Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251:186-189, 1991
78. Prendergast GC, Lawe D, Ziff EB: Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA Binding and Ras cotransformation. Cell 65:395-407, 1991
79. Prendergast GC, Hopewell R, Gorham BJ, Ziff EB: Biphasic effect of Max on Myc cotransformation activity and dependence on aminb- and carboxy-tcrminal Max functions. Genes Dev 6:2429-2439, 1992
80. Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR: Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9:59-70, 1994
81. Rao G, Alland L, Guida P, Schreiber-Agus N, Chen K, Chin L, Rochelle JM, Seldin MF, Skoultchi AI, DePinho RA: Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression domain of the Myc antagonist Mxil. Onrogojf, in press
82. Reisman D, Elkind NB, Roy B, Beamon J, Rotter V: c-Myc tram-activates the p53 promoter through a required downstream CACGTG motif. Cell Grou-th Dijf 4:57-65, 1993
83. Reitsma PH, Rothberg PG, Astrin SM, Bar-Shavit Z, Hall A, Teitelbaum SL, Kahn AJ: Regulation of myc gene expression in HL-60 leukemia cells by a vitamin D metabolite. Mature (London) 306:492-494, 1983
84. Rosenbaum H, Webb E, Adams JM, Cory S, Harris AW: N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBOJ 8:749-755, 1989
85. Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV: Increased expression of eukaryotic translation initiation factors clF-4E and eIF-2α in response to growth induction by c-myc. Proc Nail Acad Sci USA 90:6175-6178, 1993
86. Roy AL, Camithers C, Gutjahr T, Roeder RG: Direct role for Myc in transcription initiation mediated by interactions with TF1I-I. Nature (London) 365:359-361, 1993
87. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL: Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4:715-724, 1989
88. Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, Brinster RL: Pancreatic tumor pathogenesis reflects the causative generic lesion. Proc Nail Acad Sci USA 88:93-97, 1991
89. Sawai S, Shimono A, Wakamatsu Y, Palmes C, Hanaoka K, Kondoh H: Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 117:1445-1455, 1993
90. Sawey MJ, Hood AT, Bums FJ, Garte SJ: Activation of Ki-ras and c-myc oncogenes in radiation induced rat skin tumors. Mol Cell Biol 7:932-957, 1987
91. Schmid P, Schulz WA, Hameister H: Dynamic expression of the myc proto-oncogene in midgestation mouse embryos. Science 243:226-229, 1989
92. Schmidt E, Pattengale P, Weir L, Leder P: Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a prc-B-cell lymphoma model. Pro: Nail Atad Sci USA 85:6047-6051, 1988
93. Schreiber-Agus N, Hornet J, Torres R, Chiu F-C, DePinho RA: Zebra Fish myr Family and max Genes: differential expression and oncogenic activity throughout vertebrate evolution. Mol Cell Bid 13:2765-2775, 1993
94. Schreiber-Agus N, Chin L, Chen K, Torres R, Thomson C, Sacchettini JC, DePinho RA: Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxil. Oncogenc 9:3167-3177, 1994
95. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi A-I, DePinho RA: An amino-terminal domain of Mxil mediates anti-myc oncogenic activity and interacts with a homolog of the yeast transcriptional represser SIN3. Cell 80:777-786, 1995
96. Schwab M, Alitalo K, Klempnauer L, Varmus H, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J: Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (London) 305:245-248, 1983
97. Schwab M, Varmus HE, Bishop JM: Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature (London) 316:160-162, 1985
98. Sheiness DK, Bishop JM: DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J Viral 31:514-518, 1979
99. Sheiness DK, Hughes SH, Varmus HE, Stubblefield E, Bishop JM: The vertebrate homolog of the putative transforming gene of avian myelocytomatosis virus: characteristics of the DNA locus and its RNA transcript. Vital 105:415-424, 1980
100. Sinn E, Muller W, Pattcngale RK, Tepler I, Wallace R, Leder P: Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49:465-476, 1987
101. Small M, Hay N, Schwab M, BishopJM: Neoplastic transformation by the human gene N-myc. Mol Cell Biol 7:1638-1645, 1987
102. Stanton BR, Perkins AS, TessaroIIo L, Sassoon DA, Parada LF: Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Cents Dev 6:2235-2247, 1992
103. Sternberg P\V, Stern MJ, Clark I, Herskowitz I: Activation of the yeast HO gene by release from multiple negative controls. Cell 48:567-577, 1987
104. Stewart TA, Pattengale PK, Leder P: Spontaneous mammary adenocarcinomas in transgenic mice that cany and express MTV/myc fusion genes. Cell 38:627-637, 1984
105. Stone J, deLange T, Ramsay G, Jakobovits F, Bishop JM, Varmus H, Lee W: Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol 7:1697-1709, 1987
106. Strich R, Slater MR, Esposito RE: Identification of negative regulatory genes that govern the expression of early meioric genes in yeast. Proc Nad Acad Sci USA 86:10018-10022, 1989
107. Suda Y, Aizawa S, Hirai S, Inoue T, Furuta Y, Suzuke M, Hirohashi S, Ikawa Y: Driven by the same Ig enhance and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. EMBOJ 6:4055-4065, 1987
108. Vastrik I, Kaipaincn A, Pcnttila TL, Lymboussakis A, Alitalo R, Parvinen M, Alitalo K: Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitra. J Cell Biol 128:1197-1208, 1995
109. Vidai M, Strich R, Esposito RE, Gaber RF: RPD1 (SIN3/UME4) is required for maximal activation and repression of diverse yeast genes. Mol Cell Biûl 11:6306-6316, 1991
110. Wang H, Stillman DJ: Transcriptional repression in Saccharomyces cerei'isiae by a SIN3-LexA fusion protein. Met Cell Biol 13:1805-1814, 1993
111. Wang H, Clark I, Nicholson PR, Herskowitz I, Stillman DJ: The Saccharomyces cerevisiat SIN3 gene, a negative regulator of HO, contains four paired amphipathic helix motifs. Mol Cell Biol 10:5927-5936, 1990
112. Wenzel A, Cziepluch C, Hamann U, Schwab M: The N-Myc oncoprotein is associated in vivo with the phophoprotein Max (P20/22) in human ncuroblastoma cells. EMBOJ 10:3703-3712, 1991
113. Yancopoulos GD, Nisen PD, Tesfaye A, Kohl NE, Goldfarb MP, Alt FW: N-myc can cooperate with ras to transform normal cells in culture. Proc Natl Acaà Sa USA 83:5455-5459, 1985
114. Yukawa K, Kikutani H, Inomoto F, Uehira M, Sun Hui Bin, Akagi K, Yamamura K, Kishimoyo T: Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice. J Exp Med 170:711-726, 1989
115. Yuspa SH, Morgan DL: Mouse skin cells resistant to tcnninal differentiation associated with initiation of carcinogenesis. Nature (London) 293:72-74, 1981
116. Zervos AS, Gyuris J, Brent R: Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232, 1993
117. Zimmcrman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE, Minna JD, Alt FW: Differential expression of myc family genes during rnurine development. Nature 319:780-783, 1986